Show simple item record

dc.contributor.authorBoard, Editorial
dc.date2021-11-25T13:35:00.000
dc.date.accessioned2021-11-26T11:51:45Z
dc.date.available2021-11-26T11:51:45Z
dc.date.issued2013-02-25T11:56:07-08:00
dc.identifieryjhple/vol3/iss2/4
dc.identifier.contextkey3771809
dc.identifier.urihttp://hdl.handle.net/20.500.13051/6006
dc.description.abstractThe human devastation wrought by the AIDS epidemic has focused attention on the desperate need for essential medicines in the developing world. Recently, research universities in the United States have been pressured to take actions to increase access to essential medicines. Universities play a central role in the development of new medicines, and control important medical patents. Their commitment to serving the public raises important questions about what measures they can and should take to see their creations shared around the world.
dc.titleWhat role should research universities play in ensuring access to essential medicines in the developing world?
dc.source.journaltitleYale Journal of Health Policy, Law, and Ethics
refterms.dateFOA2021-11-26T11:51:46Z
dc.identifier.legacycoverpagehttps://digitalcommons.law.yale.edu/yjhple/vol3/iss2/4
dc.identifier.legacyfulltexthttps://digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article=1067&context=yjhple&unstamped=1


Files in this item

Thumbnail
Name:
22_3YaleJHealthPolyL_Ethics291 ...
Size:
82.23Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record